These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Possible role of viruses in atherosclerosis. Shih JC; Kelemen DW Adv Exp Med Biol; 1995; 369():89-98. PubMed ID: 7598020 [TBL] [Abstract][Full Text] [Related]
26. Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: weighing the evidence. High KP Clin Infect Dis; 1999 Apr; 28(4):746-9. PubMed ID: 10825031 [TBL] [Abstract][Full Text] [Related]
28. Infectious agents in coronary artery disease: viral infection, aspirin, and gene expression in human coronary smooth muscle cells. Speir E; Yu ZX; Ferrans VJ Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II33-9. PubMed ID: 9835780 [TBL] [Abstract][Full Text] [Related]
29. [Role of inflammation and infection in the etiopathogenesis of atheromatosis--literature review]. Czech B; Kucewicz E; Pawlak S Wiad Lek; 2004; 57(11-12):659-62. PubMed ID: 15865245 [TBL] [Abstract][Full Text] [Related]
30. Infectious causes of atherosclerosis. Kuvin JT; Kimmelstiel CD Am Heart J; 1999 Feb; 137(2):216-26. PubMed ID: 9924154 [No Abstract] [Full Text] [Related]
31. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471 [TBL] [Abstract][Full Text] [Related]
32. Development of atherosclerosis and infectious agents. Yamamoto M Intern Med; 2003 Jul; 42(7):547-8. PubMed ID: 12879941 [No Abstract] [Full Text] [Related]
33. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Adam E; Melnick JL; Probtsfield JL; Petrie BL; Burek J; Bailey KR; McCollum CH; DeBakey ME Lancet; 1987 Aug; 2(8554):291-3. PubMed ID: 2886763 [TBL] [Abstract][Full Text] [Related]
34. Cytomegalovirus infection and indirect sequelae in the immunocompromised transplant patient. Ho M Transplant Proc; 1991 Apr; 23(2 Suppl 1):2-7. PubMed ID: 1647559 [No Abstract] [Full Text] [Related]
35. Murine cytomegalovirus infection leads to increased levels of transplant arteriosclerosis in a murine aortic allograft model. Heim C; Abele-Ohl S; Eckl S; Ramsperger-Gleixner M; Mahmoudian S; Weyand M; Stamminger T; Ensminger SM Transplantation; 2010 Aug; 90(4):373-9. PubMed ID: 20585280 [TBL] [Abstract][Full Text] [Related]
36. Lessons for atherosclerosis research from tuberculosis and peptic ulcer. Sutter MC CMAJ; 1995 Mar; 152(5):667-70. PubMed ID: 7882229 [TBL] [Abstract][Full Text] [Related]
37. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Nieto FJ; Adam E; Sorlie P; Farzadegan H; Melnick JL; Comstock GW; Szklo M Circulation; 1996 Sep; 94(5):922-7. PubMed ID: 8790026 [TBL] [Abstract][Full Text] [Related]
38. Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Zhou YF; Shou M; Guetta E; Guzman R; Unger EF; Yu ZX; Zhang J; Finkel T; Epstein SE Circulation; 1999 Oct; 100(14):1569-75. PubMed ID: 10510062 [TBL] [Abstract][Full Text] [Related]
39. CMV endothelitis as a factor in the pathogenesis of atherosclerosis. Levi M Cardiovasc Res; 2001 Jun; 50(3):432-3. PubMed ID: 11376618 [No Abstract] [Full Text] [Related]
40. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. Fong IW CMAJ; 2000 Jul; 163(1):49-56. PubMed ID: 10920732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]